Thomas Andrew Jepps

Thomas Andrew Jepps

Auto-generated profile, based on publicly available information

Thomas Andrew Jepps

Department of Biomedical Sciences, University of Copenhagen

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2011 in Circulation
Verified
Journal Article
Closed access
PDF file
TJThomas A. Jepps
Thomas A. Jepps
PCPreet S. Chadha
Preet S. Chadha
ADAlison J. Davis
Alison J. Davis
MHMaksym I. Harhun
Maksym I. Harhun
GCGillian W. Cockerill
Gillian W. Cockerill
IGIain A. Greenwood
Iain A. Greenwood
Background—: Voltage-gated potassium (K + ) channels encoded by KCNQ genes (Kv7 channels) have been identified in various rodent and human blood vessels as key regulators of vascular tone; however, nothing is known about the functional impact of these channels in vascular disease. We ascertained the effect of 3 structurally different activators of Kv7.2 through Kv7.5 channels (BMS-204352, S-1, and retigabine) on blood vessels from normotensive and hypertensive animals. Methods and Results—: Precontracted thoracic aorta and mesenteric artery segments from normotensive rats were relaxed by all 3 Kv7 activators, with potencies of BMS-204352=S-1>retigabine. We also tested these agents in the coronary circulation using the Langendorff heart preparation. BMS-204352 and S-1 dose dependently increased coronary perfusion at concentrations between 0.1 and 10 μmol/L, whereas retigabine was effective at 1 to 10 μmol/L. In addition, S-1 increased K + currents in isolated mesenteric artery myocytes. The ability of these agents to relax precontracted vessels, increase coronary flow, or augment K + currents was impaired considerably in tissues isolated from spontaneously hypertensive rats (SHRs). Of the 5 KCNQ genes, only the expression of KCNQ4 was reduced (≈3.7 fold) in SHRs aorta. Kv7.4 protein levels were ≈50% lower in aortas and mesenteric arteries from spontaneously hypertensive rats compared with normotensive vessels. A similar attenuated response to S-1 and decreased Kv7.4 were observed in mesenteric arteries from mice made hypertensive by angiotensin II infusion compared with normotensive controls. Conclusions—: In 2 different rat and mouse models of hypertension, the functional impact of Kv7 channels was dramatically downregulated.

14 September 2010 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
FNFu Liang Ng
Fu Liang Ng
ADAlison J Davis
Alison J Davis
TJThomas A Jepps
Thomas A Jepps
MHMaksym I Harhun
Maksym I Harhun
SYShuk Yin Yeung
Shuk Yin Yeung
IGIain A Greenwood
Iain A Greenwood
BACKGROUND AND PURPOSEKCNQ‐encoded voltage‐gated potassium channels (Kv7) have recently been identified as important anti‐constrictor elements in rodent blood vessels but the role of these channels and the effects of their modulation in human arteries remain unknown. Here, we have assessedKCNQgene expression and function in human arteriesex vivo.EXPERIMENTAL APPROACHFifty arteries (41 from visceral adipose tissue, 9 mesenteric arteries) were obtained from subjects undergoing elective surgery. Quantitative RT‐PCR experiments using primers specific for all knownKCNQgenes and immunohistochemsitry were used to show Kv7 channel expression. Wire myography and single cell electrophysiology assessed the function of these channels.KEY RESULTSKCNQ4 was expressed in all arteries assessed, with variable contributions fromKCNQ1, 3 and 5.KCNQ2 was not detected. Kv7 channel isoform‐dependent staining was revealed in the smooth muscle layer. In functional studies, the Kv7 channel blockers, XE991 and linopirdine increased isometric tension and inhibited K+currents. In contrast, the Kv7.1‐specific blocker chromanol 293B did not affect vascular tone. Two Kv7 channel activators, retigabine and acrylamide S‐1, relaxed preconstricted arteries, actions reversed by XE991. Kv7 channel activators also suppressed spontaneous contractile activity in seven arteries, reversible by XE991.CONCLUSIONS AND IMPLICATIONSThis is the first study to demonstrate not only the presence ofKCNQgene products in human arteries but also their contribution to vascular toneex vivo.LINKED ARTICLEThis article is commented on by Mani and Byron, pp. 38–41 of this issue. To view this commentary visithttp://dx.doi.org/10.1111/j.1476‐5381.2010.01065.x

1 November 2010 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
ADAlison J. Davis
Alison J. Davis
AFAbigail S. Forrest
Abigail S. Forrest
TJThomas A. Jepps
Thomas A. Jepps
MVMaria L. Valencik
Maria L. Valencik
MWMichael Wiwchar
Michael Wiwchar
NLNormand Leblanc
Normand Leblanc
Recently, overexpression of the genes TMEM16A and TMEM16B has been shown to produce currents qualitatively similar to native Ca2+-activated Cl− currents ( IClCa) in vascular smooth muscle. However, there is no information about this new gene family in vascular smooth muscle, where Cl− channels are a major depolarizing mechanism. Qualitatively similar Cl− currents were evoked by a pipette solution containing 500 nM Ca2+ in smooth muscle cells isolated from BALB/c mouse portal vein, thoracic aorta, and carotid artery. Quantitative PCR using SYBR Green chemistry and primers specific for transmembrane protein (TMEM) 16A or the closely related TMEM16B showed TMEM16A expression as follows: portal vein > thoracic aorta > carotid artery > brain. In addition, several alternatively spliced variant transcripts of TMEM16A were detected. In contrast, TMEM16B expression was very low in smooth muscle. Western blot analysis with different antibodies directed against TMEM16A revealed a number of products with a consistent band at ∼120 kDa, except portal vein, where an 80-kDa band predominated. TMEM16A protein was identified in the smooth muscle layers of 4-μm-thick slices of portal vein, thoracic aorta, and carotid artery. In isolated myocytes, fluorescence specific to a TMEM16A antibody was detected diffusely throughout the cytoplasm, as well as near the membrane. The same antibody used in Western blot analysis of lysates from vascular tissues also recognized an ∼147-kDa mouse TMEM16A-green fluorescent protein (GFP) fusion protein expressed in HEK 293 cells, which correlated to a similar band detected by a GFP antibody. Patch-clamp experiments revealed that IClCa generated by transfection of TMEM16A-GFP in HEK 293 cells displayed remarkable similarities to IClCa recorded in vascular myocytes, including slow kinetics, steep outward rectification, and a response similar to the pharmacological agent niflumic acid. This study shows that TMEM16A expression is robust in murine vascular smooth muscle cells, consolidating the view that this gene is a viable candidate for the native Ca2+-activated Cl− channel in this cell type.

1 April 2012 in Hypertension
Verified
Journal Article
Closed access
PDF file
PCPreet S. Chadha
Preet S. Chadha
FZFriederike Zunke
Friederike Zunke
HZHai-Lei Zhu
Hai-Lei Zhu
ADAlison J. Davis
Alison J. Davis
TJThomas A. Jepps
Thomas A. Jepps
IGIain A. Greenwood
Iain A. Greenwood
KCNQ4-encoded voltage-dependent potassium (Kv7.4) channels are important regulators of vascular tone that are severely compromised in models of hypertension. However, there is no information as to the role of these channels in responses to endogenous vasodilators. We used a molecular knockdown strategy, as well as pharmacological tools, to examine the hypothesis that Kv7.4 channels contribute to β-adrenoceptor–mediated vasodilation in the renal vasculature and underlie the vascular deficit in spontaneously hypertensive rats. Quantitative PCR and immunohistochemistry confirmed gene and protein expression of KCNQ1, KCNQ3, KCNQ4, KCNQ5, and Kv7.1, Kv7.4, and Kv7.5 in rat renal artery. Isoproterenol produced concentration-dependent relaxation of precontracted renal arteries and increased Kv7 channel currents in isolated smooth muscle cells. Application of the Kv7 blocker linopirdine attenuated isoproterenol-induced relaxation and current. Isoproterenol-induced relaxations were also reduced in arteries incubated with small interference RNAs targeted to KCNQ4 that produced a ≈60% decrease in Kv7.4 protein level. Relaxation to isoproterenol and the Kv7 activator S-1 were abolished in arteries from spontaneously hypertensive rats, which was associated with ≈60% decrease in Kv7.4 abundance. This study provides the first evidence that Kv7 channels contribute to β-adrenoceptor–mediated vasodilation in the renal vasculature and that abrogation of Kv7.4 channels is strongly implicated in the impaired β-adrenoceptor pathway in spontaneously hypertensive rats. These findings may provide a novel pathogenic link between arterial dysfunction and hypertension.

1 April 2014 in Drug Discovery Today
Verified
Journal Article
Closed access
JSJennifer B. Stott
Jennifer B. Stott
TJThomas A. Jepps
Thomas A. Jepps
IGIain A. Greenwood
Iain A. Greenwood

1 April 2014 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
PCPreet S. Chadha
Preet S. Chadha
TJThomas A. Jepps
Thomas A. Jepps
GCGeorgina Carr
Georgina Carr
JSJennifer B. Stott
Jennifer B. Stott
HZHei-Lei Zhu
Hei-Lei Zhu
IGIain A. Greenwood
Iain A. Greenwood
Objective—: Middle cerebral artery (MCA) diameter is regulated by inherent myogenic activity and the effect of potent vasodilators such as calcitonin gene-related peptide (CGRP). Previous studies showed that MCAs express KCNQ1, 4, and 5 potassium channel genes, and the expression products (Kv7 channels) participate in the myogenic control of MCA diameter. The present study investigated the contribution of Kv7.4 and Kv7.5 isoforms to myogenic and CGRP regulation of MCA diameter and determined whether they were affected in hypertensive animals.Approach and Results—: Isometric tension recordings performed on MCA from normotensive rats produced CGRP vasodilations that were inhibited by the pan-Kv7 channel blocker linopirdine (P<0.01) and after transfection of arteries with siRNA against KCNQ4 (P<0.01) but not KCNQ5. However, isobaric myography revealed that myogenic constriction in response to increases in intravascular pressure (20–80 mm Hg) was affected by both KCNQ4 and KCNQ5 siRNA. Proximity ligation assay signals were equally abundant for Kv7.4/Kv7.4 or Kv7.4/Kv7.5 antibody combinations but minimal for Kv7.5/Kv7.5 antibodies or Kv7.4/7.1 combinations. In contrast to systemic arteries, Kv7 function and Kv7.4 abundance in MCA were not altered in hypertensive rats.Conclusions—: This study reveals, for the first time to our knowledge, that in cerebral arteries, Kv7.4 and Kv7.5 proteins exist predominantly as a functional heterotetramer, which regulates intrinsic myogenicity and vasodilation attributed to CGRP. Surprisingly, unlike systemic arteries, Kv7 activity in MCAs is not affected by the development of hypertension, and CGRP-mediated vasodilation is well maintained. As such, cerebrovascular Kv7 channels could be amenable for therapeutic targeting in conditions such as cerebral vasospasm.